Leadgene Biomedical

Latest News

Leadgene Biomedical Develops Next-Generation Platforms to Strengthen CDMO Integration in Global Markets

As global supply chains undergo restructuring, the biotech and pharmaceutical sectors are increasingly influenced by geopolitical risks and U.S. trade policies. These dynamics are prompting companies worldwide to rethink their manufacturing strategies and seek reliable Contract Development and Manufacturing Organization (CDMO) partners that offer stability, quality, and technological sophistication.

Developing Next Generation Diagnostic Biological Reagents

Leadgene develops cutting-edge technologies and high-quality biological raw materials reagents. Its recent achievements and expansion plans aim to push medical and geographic boundaries

Is Your Kidney Health at Risk? Early Screening and Treatment Are Crucial for High-Risk Groups

Traditional Diagnostics Have Limitations—How a 30-Year-Old Man Was Diagnosed with Early Kidney Disease Using This Biomarker

1

/

3

New Distributor Announcement - EZchemtech Inc.

Chronic Kidney Disease Emerges as a Silent Killer – Experts Stress the Need for Accurate Diagnostics

Successful Registration of Key Products in US FDA DMF

Leadgene Biomedical Completes 100% Acquisition of SIDSCO to Drive Business Integration and Maximize Synergy

Leadgene Indoxyl Sulfate (IS) ELISA Kit Awarded the 2024 Symbol of National Quality (SNQ)

Leadgene Biomedical at the 2024 Healthcare+ Expo Taiwan!

Meet us at MEDICA Düsseldorf 2024!

Meet Us at MEDICAL FAIR ASIA 2024!

Leadgene Biomedical Expands in Northern Taiwan with New Innovation & Research Center and CLD Center

New Distributor Announcement - BioCell Corporation

Leadgene Biomedical, CYTENA BPS, and CYTENA Forge Tripartite Collaboration to Establish Cell Line Development Platform

Innovative Patented In Vitro Diagnostics Receives Market Approval

1
2
3